부데소니드 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 예측 기간의 성장은 숨쉬기 쉬운 노인 인구 증가, 부데소니드의 제네릭 제품의 확대 등에 기인한다고 생각됩니다. 이 기간에 예상되는 주요 동향에는 생물 제제 및 바이오시밀러의 채용, 약물전달 시스템의 혁신, 신제제의 규제 승인, 지속적인 기술 진보 등이 있습니다.
호흡기 질환의 유병률 상승은 부데소니드 시장의 성장을 가속할 것으로 예측됩니다. 이 환경 요인은 천식과 만성 폐쇄성 폐 질환(COPD)과 같은 증상에 크게 기여합니다. 예를 들어, 미국 국립보건통계센터(NCHS)에 따르면 미국 성인의 천식 유병률은 2021년 8.4%에서 2022년 8.7%로 증가했으며, 같은 기간 천식 발병률은 3.3%에서 3.7%로 증가했습니다.
부데소니드 시장의 기업은 치료효과와 환자의 어드히어런스를 높이기 위해 혁신적인 경구·흡입요법에 주력하고 있습니다. 예를 들어, 다케다제약은 2024년 2월, 11세 이상의 호산구성 식도염(EoE) 환자를 위한 최초이자 유일한 경구용 부데소니드 현탁액인 EOHILIA에 대해 FDA 승인을 받았습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 부데소니드 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 부데소니드 시장 : 성장률 분석
- 세계의 부데소니드 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 부데소니드 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 부데소니드 전체 시장(TAM)
제6장 시장 세분화
- 세계의 부데소니드 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 흡입 분말
- 에어로졸
- 주사용 현탁액
- 정제 및 캡슐
- 세계의 부데소니드 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 부데소니드 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 코 질환 치료
- 염증성 장 질환 치료
- 호흡기 질환 치료
- 기타 용도
- 세계의 부데소니드 시장 : 흡입 분말 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 건조 분말 흡입기(DPI)
- 소프트 미스트 흡입기(SMI)
- 세계의 부데소니드 시장 : 에어로졸 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 정량 흡입기(MDI)
- 호흡 활성화 흡입기
- 세계의 부데소니드 시장 : 주사용 현탁액 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 사전 충전 주사기
- 바이알
- 세계의 부데소니드 시장 : 정제 및 캡슐 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 경구용 정제
- 경구용 캡슐
제7장 지역별/국가별 분석
- 세계의 부데소니드 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 부데소니드 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 부데소니드 시장 : 경쟁 구도
- 부데소니드 시장 : 기업 프로파일
- AstraZeneca AB 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Takeda Pharmaceuticals Company Limited 개요, 제품 및 서비스, 전략 및 재무 분석
- Viatris Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Teva Pharmaceutical Industries Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Sandoz AG
- Aurobindo Pharma Limited
- Chiesi Farmaceutici SpA
- Cipla Limited
- Lupin Limited
- Orion Corporation
- Salix Pharmaceuticals Inc.
- Synmosa Biopharma Corporation
- Cosmo Pharmaceuticals NV
- Skyepharma Holdings Inc.
- Manus Aktteva Biopharma LLP
- Cennet Biopharma Private Limited
- Santarus Inc.
- SiNi Pharma Private Limited
- Shanghai Sine Promod Pharmaceutical Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 부데소니드 시장(2029년) : 새로운 기회를 제공하는 국가
- 부데소니드 시장(2029년) : 새로운 기회를 제공하는 부문
- 부데소니드 시장(2029년) : 성장 전략
제36장 부록
KTH
Budesonide is a corticosteroid medication used to reduce inflammation in conditions such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory bowel diseases (including Crohn's disease and ulcerative colitis), and allergic rhinitis. It functions by suppressing the immune response and reducing inflammation in the airways or digestive tract.
The primary forms of budesonide include inhalation powder, aerosols, injectable suspensions, tablets, and capsules. Inhalation budesonide powder is a corticosteroid delivered via a dry powder inhaler to reduce airway inflammation in respiratory conditions. Budesonide is distributed through hospital pharmacies, retail pharmacies, and online pharmacies and is used for various applications, including the treatment of nasal diseases, inflammatory bowel diseases, respiratory diseases, and other conditions.
The budesonide market research report is one of a series of new reports from The Business Research Company that provides budesonide market statistics, including the budesonide industry global market size, regional shares, competitors with the budesonide market share, detailed budesonide market segments, market trends, and opportunities, and any further data you may need to thrive in the budesonide industry. This budesonide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The budesonide market size has grown strongly in recent years. It will grow from $9.72 billion in 2024 to $10.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth during the historic period can be attributed to the increasing prevalence of respiratory diseases, greater awareness of inhaled corticosteroids, the introduction of budesonide-based combination therapies, the expansion of healthcare access and infrastructure, and the adoption of budesonide for off-label use in inflammatory bowel diseases.
The budesonide market size is expected to see strong growth in the next few years. It will grow to $13.25 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth during the forecast period can be attributed to the increasing demand for effective treatments, advancements in novel drug delivery systems, rising use of budesonide, a growing geriatric population prone to asthma, and the expansion of generic budesonide products. Key trends expected in this period include the adoption of biologics and biosimilars, innovations in drug delivery systems, regulatory approvals for new formulations, and ongoing technological advancements.
The rising prevalence of respiratory diseases is expected to drive the growth of the budesonide market. Respiratory diseases, which impact the organs and tissues responsible for gas exchange, are increasing due to factors such as rising air pollution, exposure to particulate matter, and allergens. These environmental factors contribute significantly to conditions such as asthma and chronic obstructive pulmonary disease (COPD). Budesonide, a corticosteroid, is commonly used to manage these respiratory diseases by reducing inflammation, improving airflow, and preventing symptoms such as wheezing and shortness of breath. For instance, according to the National Center for Health Statistics (NCHS), the prevalence of asthma among adults in the U.S. increased from 8.4% in 2021 to 8.7% in 2022, with asthma episodes rising from 3.3% to 3.7% during the same period. Consequently, the growing incidence of respiratory diseases is expected to fuel the expansion of the budesonide market.
Companies in the budesonide market are focusing on innovative oral and inhaled therapies to enhance treatment effectiveness and patient adherence. Oral formulations of budesonide provide a convenient treatment option, especially for inflammatory conditions. For example, in February 2024, Takeda Pharmaceuticals received FDA approval for EOHILIA, the first and only FDA-approved oral budesonide suspension for patients aged 11 and above with eosinophilic esophagitis (EoE). This approval was based on positive efficacy and safety data from clinical trials, demonstrating the potential of oral budesonide in expanding treatment options for respiratory and inflammatory diseases.
In March 2023, Cheplapharm Arzneimittel GmbH acquired the U.S. commercial rights for PULMICORT FLEXHALER from AstraZeneca. This acquisition allows Cheplapharm to diversify its product offerings and expand its presence in the U.S. pharmaceutical market while ensuring continued availability of PULMICORT FLEXHALER, a widely used budesonide-based asthma treatment. AstraZeneca, a UK-based biopharmaceutical company, has long been a key player in developing and marketing PULMICORT for respiratory conditions such as asthma and COPD.
Major players in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, and Shanghai Sine Promod Pharmaceutical Co. Ltd.
North America was the largest region in the budesonide market in 2024. The regions covered in budesonide report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the budesonide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The budesonide market consists of sales of nebulizer suspension, inhalers, and nasal sprays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Budesonide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on budesonide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for budesonide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The budesonide market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Inhalation Powder; Aerosols; Injectable Suspension; Tablets And Capsules
- 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- 3) By Application: Nose Disease Treatment; Inflammatory Bowel Disease Treatment; Respiratory Disease Treatment; Other Applications
- Subsegments:
- 1) By Inhalation Powder: Dry Powder Inhalers (DPI); Soft Mist Inhalers (SMI)
- 2) By Aerosols: Metered-Dose Inhalers (MDI); Breath-Activated Inhalers
- 3) By Injectable Suspension: Pre-filled Syringes; Vials
- 4) By Tablets And Capsules: Oral Tablets; Oral Capsules
- Companies Mentioned: AstraZeneca AB; Novartis AG; Takeda Pharmaceuticals Company Limited; Viatris Inc.; Teva Pharmaceutical Industries Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Budesonide Market Characteristics
3. Budesonide Market Trends And Strategies
4. Budesonide Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Budesonide Growth Analysis And Strategic Analysis Framework
- 5.1. Global Budesonide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Budesonide Market Growth Rate Analysis
- 5.4. Global Budesonide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Budesonide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Budesonide Total Addressable Market (TAM)
6. Budesonide Market Segmentation
- 6.1. Global Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inhalation Powder
- Aerosols
- Injectable Suspension
- Tablets And Capsules
- 6.2. Global Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.3. Global Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Respiratory Disease Treatment
- Other Applications
- 6.4. Global Budesonide Market, Sub-Segmentation Of Inhalation Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dry Powder Inhalers (DPI)
- Soft Mist Inhalers (SMI)
- 6.5. Global Budesonide Market, Sub-Segmentation Of Aerosols, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Metered-Dose Inhalers (MDI)
- Breath-Activated Inhalers
- 6.6. Global Budesonide Market, Sub-Segmentation Of Injectable Suspension, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pre-filled Syringes
- Vials
- 6.7. Global Budesonide Market, Sub-Segmentation Of Tablets And Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Tablets
- Oral Capsules
7. Budesonide Market Regional And Country Analysis
- 7.1. Global Budesonide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Budesonide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Budesonide Market
- 8.1. Asia-Pacific Budesonide Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Budesonide Market
- 9.1. China Budesonide Market Overview
- 9.2. China Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Budesonide Market
- 10.1. India Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Budesonide Market
- 11.1. Japan Budesonide Market Overview
- 11.2. Japan Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Budesonide Market
- 12.1. Australia Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Budesonide Market
- 13.1. Indonesia Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Budesonide Market
- 14.1. South Korea Budesonide Market Overview
- 14.2. South Korea Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Budesonide Market
- 15.1. Western Europe Budesonide Market Overview
- 15.2. Western Europe Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Budesonide Market
- 16.1. UK Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Budesonide Market
- 17.1. Germany Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Budesonide Market
- 18.1. France Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Budesonide Market
- 19.1. Italy Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Budesonide Market
- 20.1. Spain Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Budesonide Market
- 21.1. Eastern Europe Budesonide Market Overview
- 21.2. Eastern Europe Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Budesonide Market
- 22.1. Russia Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Budesonide Market
- 23.1. North America Budesonide Market Overview
- 23.2. North America Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Budesonide Market
- 24.1. USA Budesonide Market Overview
- 24.2. USA Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Budesonide Market
- 25.1. Canada Budesonide Market Overview
- 25.2. Canada Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Budesonide Market
- 26.1. South America Budesonide Market Overview
- 26.2. South America Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Budesonide Market
- 27.1. Brazil Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Budesonide Market
- 28.1. Middle East Budesonide Market Overview
- 28.2. Middle East Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Budesonide Market
- 29.1. Africa Budesonide Market Overview
- 29.2. Africa Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Budesonide Market Competitive Landscape And Company Profiles
- 30.1. Budesonide Market Competitive Landscape
- 30.2. Budesonide Market Company Profiles
- 30.2.1. AstraZeneca AB Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Takeda Pharmaceuticals Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Budesonide Market Other Major And Innovative Companies
- 31.1. Sandoz AG
- 31.2. Aurobindo Pharma Limited
- 31.3. Chiesi Farmaceutici S.p.A.
- 31.4. Cipla Limited
- 31.5. Lupin Limited
- 31.6. Orion Corporation
- 31.7. Salix Pharmaceuticals Inc.
- 31.8. Synmosa Biopharma Corporation
- 31.9. Cosmo Pharmaceuticals N.V.
- 31.10. Skyepharma Holdings Inc.
- 31.11. Manus Aktteva Biopharma LLP
- 31.12. Cennet Biopharma Private Limited
- 31.13. Santarus Inc.
- 31.14. SiNi Pharma Private Limited
- 31.15. Shanghai Sine Promod Pharmaceutical Co. Ltd.
32. Global Budesonide Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Budesonide Market
34. Recent Developments In The Budesonide Market
35. Budesonide Market High Potential Countries, Segments and Strategies
- 35.1 Budesonide Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Budesonide Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Budesonide Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
